Salmonella enterica serotypes and antibiotic susceptibility in New Zealand, 2002–2007
We analysed the serotypes and antibiotic susceptibility of 1560 human and 1505 non-human Salmonella isolated in New Zealand (NZ) between 2002 and 2007. The most common serotypes in humans were Salmonella enterica serovar Typhimurium, S. Enteritidis, S. Brandenburg and S. Infantis. Over the 6-year pe...
Gespeichert in:
| Veröffentlicht in: | Epidemiology and infection 2010-03, Vol.138 (3), p.322-329 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 329 |
|---|---|
| container_issue | 3 |
| container_start_page | 322 |
| container_title | Epidemiology and infection |
| container_volume | 138 |
| creator | BROUGHTON, E. I. HEFFERNAN, H. M. COLES, C. L. |
| description | We analysed the serotypes and antibiotic susceptibility of 1560 human and 1505 non-human Salmonella isolated in New Zealand (NZ) between 2002 and 2007. The most common serotypes in humans were Salmonella enterica serovar Typhimurium, S. Enteritidis, S. Brandenburg and S. Infantis. Over the 6-year period human cases due to S. Agona and S. Enteritidis increased and cases due to S. Typhimurium decreased. The most common serotypes from non-human sources were S. Typhimurium, S. Brandenberg, S. Hindmarsh and S. Infantis, and there were no significant changes over time. More isolates were non-susceptible to streptomycin than to any other antibiotic. Almost all isolates were susceptible to ciprofloxacin and gentamicin. There were significant trends of increasing non-susceptibility to streptomycin and sulfonamides in isolates from human and non-human sources, while ampicillin, tetracycline and multidrug non-susceptibility also increased in human isolates. Despite these increases, rates of antibiotic non-susceptibility in Salmonella in NZ are still lower than in many international settings. |
| doi_str_mv | 10.1017/S0950268809990458 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_734252570</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S0950268809990458</cupid><jstor_id>40390566</jstor_id><sourcerecordid>40390566</sourcerecordid><originalsourceid>FETCH-LOGICAL-c492t-e9b05d22f924ba9898b1c847d85733b2cd741daf0d36808b2c8cf3779c56c8ea3</originalsourceid><addsrcrecordid>eNp9kc2KFDEUhYMoTtv6AC6UQnDcWHrznyxlcMZhRkVaUdyEVColaeunTarQ3s07-IY-iWm66AFFF-GSnO9e7slB6D6GZxiwfL4CzYEIpUBrDYyrG2iBmdAlY6BvosVOLnf6EbqT0hoANFHyNjrCWnCqCVugjyvbdkPv29YWvh99DM4Wycdh3G58Kmxf5zOGKgxjcEWakvOb3bUN47YIffHGfy8-e9tm8GlBAMivq5-5yLvoVmPb5O_NdYk-nL58f_KqvHx7dn7y4rJ0TJOx9LoCXhPS5GUqq5VWFXaKyVpxSWlFXC0Zrm0DNRUKVH5QrqFSaseFU97SJXqyn7uJw7fJp9F0Ie-Y7fR-mJKRlBFOuIRMHv-XJJhKrBXL4KM_wPUwxT67MAQ4U5gCzxDeQy4OKUXfmE0MnY1bg8HswjF_hZN7Hs6Dp6rz9XXHnEYGHs-ATc62TbS9C-nAEUKZAE4y92DPrdM4xIPOgGrgQmS93Oshjf7HQbfxqxGSSm7E2TujTlfs0-sLnL9oiehsxnZVDPUXf23533Z-A1mZvSo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205481305</pqid></control><display><type>article</type><title>Salmonella enterica serotypes and antibiotic susceptibility in New Zealand, 2002–2007</title><source>MEDLINE</source><source>Jstor Complete Legacy</source><source>PubMed Central</source><creator>BROUGHTON, E. I. ; HEFFERNAN, H. M. ; COLES, C. L.</creator><creatorcontrib>BROUGHTON, E. I. ; HEFFERNAN, H. M. ; COLES, C. L.</creatorcontrib><description>We analysed the serotypes and antibiotic susceptibility of 1560 human and 1505 non-human Salmonella isolated in New Zealand (NZ) between 2002 and 2007. The most common serotypes in humans were Salmonella enterica serovar Typhimurium, S. Enteritidis, S. Brandenburg and S. Infantis. Over the 6-year period human cases due to S. Agona and S. Enteritidis increased and cases due to S. Typhimurium decreased. The most common serotypes from non-human sources were S. Typhimurium, S. Brandenberg, S. Hindmarsh and S. Infantis, and there were no significant changes over time. More isolates were non-susceptible to streptomycin than to any other antibiotic. Almost all isolates were susceptible to ciprofloxacin and gentamicin. There were significant trends of increasing non-susceptibility to streptomycin and sulfonamides in isolates from human and non-human sources, while ampicillin, tetracycline and multidrug non-susceptibility also increased in human isolates. Despite these increases, rates of antibiotic non-susceptibility in Salmonella in NZ are still lower than in many international settings.</description><identifier>ISSN: 0950-2688</identifier><identifier>EISSN: 1469-4409</identifier><identifier>DOI: 10.1017/S0950268809990458</identifier><identifier>PMID: 19653924</identifier><identifier>CODEN: EPINEU</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Anti-Bacterial Agents - pharmacology ; Antibiotic resistance ; Antibiotics ; antimicrobial resistance in agricultural settings ; Bacteriology ; Biological and medical sciences ; Drug Resistance, Multiple, Bacterial ; Food safety ; Fundamental and applied biological sciences. Psychology ; Humans ; Infections ; Microbiology ; Miscellaneous ; New Zealand - epidemiology ; Odds Ratio ; Population Surveillance ; Public health ; public health emerging infections ; Salmonella ; Salmonella enterica ; Salmonella enterica - classification ; Salmonella enterica - drug effects ; Salmonella infections ; Salmonella Infections - epidemiology ; Salmonella Infections - microbiology ; Salmonella typhimurium ; Salmonellae and cholera ; Serotyping ; Sulfonamides ; Surveillance ; surveillance system</subject><ispartof>Epidemiology and infection, 2010-03, Vol.138 (3), p.322-329</ispartof><rights>Copyright © Cambridge University Press 2009</rights><rights>Copyright 2010 Cambridge University Press</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c492t-e9b05d22f924ba9898b1c847d85733b2cd741daf0d36808b2c8cf3779c56c8ea3</citedby><cites>FETCH-LOGICAL-c492t-e9b05d22f924ba9898b1c847d85733b2cd741daf0d36808b2c8cf3779c56c8ea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/40390566$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/40390566$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,777,781,800,27906,27907,57999,58232</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22346052$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19653924$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BROUGHTON, E. I.</creatorcontrib><creatorcontrib>HEFFERNAN, H. M.</creatorcontrib><creatorcontrib>COLES, C. L.</creatorcontrib><title>Salmonella enterica serotypes and antibiotic susceptibility in New Zealand, 2002–2007</title><title>Epidemiology and infection</title><addtitle>Epidemiol. Infect</addtitle><description>We analysed the serotypes and antibiotic susceptibility of 1560 human and 1505 non-human Salmonella isolated in New Zealand (NZ) between 2002 and 2007. The most common serotypes in humans were Salmonella enterica serovar Typhimurium, S. Enteritidis, S. Brandenburg and S. Infantis. Over the 6-year period human cases due to S. Agona and S. Enteritidis increased and cases due to S. Typhimurium decreased. The most common serotypes from non-human sources were S. Typhimurium, S. Brandenberg, S. Hindmarsh and S. Infantis, and there were no significant changes over time. More isolates were non-susceptible to streptomycin than to any other antibiotic. Almost all isolates were susceptible to ciprofloxacin and gentamicin. There were significant trends of increasing non-susceptibility to streptomycin and sulfonamides in isolates from human and non-human sources, while ampicillin, tetracycline and multidrug non-susceptibility also increased in human isolates. Despite these increases, rates of antibiotic non-susceptibility in Salmonella in NZ are still lower than in many international settings.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>antimicrobial resistance in agricultural settings</subject><subject>Bacteriology</subject><subject>Biological and medical sciences</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>Food safety</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Infections</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>New Zealand - epidemiology</subject><subject>Odds Ratio</subject><subject>Population Surveillance</subject><subject>Public health</subject><subject>public health emerging infections</subject><subject>Salmonella</subject><subject>Salmonella enterica</subject><subject>Salmonella enterica - classification</subject><subject>Salmonella enterica - drug effects</subject><subject>Salmonella infections</subject><subject>Salmonella Infections - epidemiology</subject><subject>Salmonella Infections - microbiology</subject><subject>Salmonella typhimurium</subject><subject>Salmonellae and cholera</subject><subject>Serotyping</subject><subject>Sulfonamides</subject><subject>Surveillance</subject><subject>surveillance system</subject><issn>0950-2688</issn><issn>1469-4409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kc2KFDEUhYMoTtv6AC6UQnDcWHrznyxlcMZhRkVaUdyEVColaeunTarQ3s07-IY-iWm66AFFF-GSnO9e7slB6D6GZxiwfL4CzYEIpUBrDYyrG2iBmdAlY6BvosVOLnf6EbqT0hoANFHyNjrCWnCqCVugjyvbdkPv29YWvh99DM4Wycdh3G58Kmxf5zOGKgxjcEWakvOb3bUN47YIffHGfy8-e9tm8GlBAMivq5-5yLvoVmPb5O_NdYk-nL58f_KqvHx7dn7y4rJ0TJOx9LoCXhPS5GUqq5VWFXaKyVpxSWlFXC0Zrm0DNRUKVH5QrqFSaseFU97SJXqyn7uJw7fJp9F0Ie-Y7fR-mJKRlBFOuIRMHv-XJJhKrBXL4KM_wPUwxT67MAQ4U5gCzxDeQy4OKUXfmE0MnY1bg8HswjF_hZN7Hs6Dp6rz9XXHnEYGHs-ATc62TbS9C-nAEUKZAE4y92DPrdM4xIPOgGrgQmS93Oshjf7HQbfxqxGSSm7E2TujTlfs0-sLnL9oiehsxnZVDPUXf23533Z-A1mZvSo</recordid><startdate>20100301</startdate><enddate>20100301</enddate><creator>BROUGHTON, E. I.</creator><creator>HEFFERNAN, H. M.</creator><creator>COLES, C. L.</creator><general>Cambridge University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20100301</creationdate><title>Salmonella enterica serotypes and antibiotic susceptibility in New Zealand, 2002–2007</title><author>BROUGHTON, E. I. ; HEFFERNAN, H. M. ; COLES, C. L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c492t-e9b05d22f924ba9898b1c847d85733b2cd741daf0d36808b2c8cf3779c56c8ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>antimicrobial resistance in agricultural settings</topic><topic>Bacteriology</topic><topic>Biological and medical sciences</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>Food safety</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Infections</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>New Zealand - epidemiology</topic><topic>Odds Ratio</topic><topic>Population Surveillance</topic><topic>Public health</topic><topic>public health emerging infections</topic><topic>Salmonella</topic><topic>Salmonella enterica</topic><topic>Salmonella enterica - classification</topic><topic>Salmonella enterica - drug effects</topic><topic>Salmonella infections</topic><topic>Salmonella Infections - epidemiology</topic><topic>Salmonella Infections - microbiology</topic><topic>Salmonella typhimurium</topic><topic>Salmonellae and cholera</topic><topic>Serotyping</topic><topic>Sulfonamides</topic><topic>Surveillance</topic><topic>surveillance system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BROUGHTON, E. I.</creatorcontrib><creatorcontrib>HEFFERNAN, H. M.</creatorcontrib><creatorcontrib>COLES, C. L.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Epidemiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BROUGHTON, E. I.</au><au>HEFFERNAN, H. M.</au><au>COLES, C. L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Salmonella enterica serotypes and antibiotic susceptibility in New Zealand, 2002–2007</atitle><jtitle>Epidemiology and infection</jtitle><addtitle>Epidemiol. Infect</addtitle><date>2010-03-01</date><risdate>2010</risdate><volume>138</volume><issue>3</issue><spage>322</spage><epage>329</epage><pages>322-329</pages><issn>0950-2688</issn><eissn>1469-4409</eissn><coden>EPINEU</coden><abstract>We analysed the serotypes and antibiotic susceptibility of 1560 human and 1505 non-human Salmonella isolated in New Zealand (NZ) between 2002 and 2007. The most common serotypes in humans were Salmonella enterica serovar Typhimurium, S. Enteritidis, S. Brandenburg and S. Infantis. Over the 6-year period human cases due to S. Agona and S. Enteritidis increased and cases due to S. Typhimurium decreased. The most common serotypes from non-human sources were S. Typhimurium, S. Brandenberg, S. Hindmarsh and S. Infantis, and there were no significant changes over time. More isolates were non-susceptible to streptomycin than to any other antibiotic. Almost all isolates were susceptible to ciprofloxacin and gentamicin. There were significant trends of increasing non-susceptibility to streptomycin and sulfonamides in isolates from human and non-human sources, while ampicillin, tetracycline and multidrug non-susceptibility also increased in human isolates. Despite these increases, rates of antibiotic non-susceptibility in Salmonella in NZ are still lower than in many international settings.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><pmid>19653924</pmid><doi>10.1017/S0950268809990458</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0950-2688 |
| ispartof | Epidemiology and infection, 2010-03, Vol.138 (3), p.322-329 |
| issn | 0950-2688 1469-4409 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_734252570 |
| source | MEDLINE; Jstor Complete Legacy; PubMed Central |
| subjects | Anti-Bacterial Agents - pharmacology Antibiotic resistance Antibiotics antimicrobial resistance in agricultural settings Bacteriology Biological and medical sciences Drug Resistance, Multiple, Bacterial Food safety Fundamental and applied biological sciences. Psychology Humans Infections Microbiology Miscellaneous New Zealand - epidemiology Odds Ratio Population Surveillance Public health public health emerging infections Salmonella Salmonella enterica Salmonella enterica - classification Salmonella enterica - drug effects Salmonella infections Salmonella Infections - epidemiology Salmonella Infections - microbiology Salmonella typhimurium Salmonellae and cholera Serotyping Sulfonamides Surveillance surveillance system |
| title | Salmonella enterica serotypes and antibiotic susceptibility in New Zealand, 2002–2007 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T09%3A12%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Salmonella%20enterica%20serotypes%20and%20antibiotic%20susceptibility%20in%20New%20Zealand,%202002%E2%80%932007&rft.jtitle=Epidemiology%20and%20infection&rft.au=BROUGHTON,%20E.%20I.&rft.date=2010-03-01&rft.volume=138&rft.issue=3&rft.spage=322&rft.epage=329&rft.pages=322-329&rft.issn=0950-2688&rft.eissn=1469-4409&rft.coden=EPINEU&rft_id=info:doi/10.1017/S0950268809990458&rft_dat=%3Cjstor_proqu%3E40390566%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=205481305&rft_id=info:pmid/19653924&rft_cupid=10_1017_S0950268809990458&rft_jstor_id=40390566&rfr_iscdi=true |